M-TEER demonstrates life-saving potential in severe mitral regurgitation due to cardiac amyloidosis, indicating a new therapeutic option.
M-TEER may be a life-saving therapy for severe iatrogenic MR in patients with advanced cardiac amyloidosis.
No takes yet. Share an insight, caveat, or question.
Kanda et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: